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Abstract: Hypoxia and the hypoxia-inducible factor (HIF) signaling pathway trigger the expres-
sion of several genes involved in cancer progression and resistance to therapy. Transcriptionally 
active HIF-1 and HIF-2 regulate overlapping sets of target genes, and only few HIF-2 specific 
target genes are known so far. Here we investigated oxygen-regulated expression of Wnt-1 
induced signaling protein 2 (WISP-2), which has been reported to attenuate the progression of 
breast cancer. WISP-2 was hypoxically induced in low-invasive luminal-like breast cancer cell 
lines at both the messenger RNA and protein levels, mainly in a HIF-2α-dependent manner. 
 HIF-2-driven regulation of the WISP2 promoter in breast cancer cells is almost entirely medi-
ated by two phylogenetically and only partially conserved functional hypoxia response elements 
located in a microsatellite region upstream of the transcriptional start site. High WISP-2 tumor 
levels were associated with increased HIF-2α, decreased tumor macrophage density, and a better 
prognosis. Silencing WISP-2 increased anchorage-independent colony formation and recovery 
from scratches in confluent cell layers of normally low-invasive MCF-7 cancer cells.  Interestingly, 
these changes in cancer cell aggressiveness could be phenocopied by HIF-2α silencing, sug-
gesting that direct HIF-2-mediated transcriptional induction of WISP-2 gene expression might 
at least partially explain the association of high HIF-2α tumor levels with prolonged overall 
survival of patients with breast cancer.
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Introduction
Temporally and spatially variable tissue hypoxia is characteristic of solid tumors.1 
Hypoxia-inducible factors (HIFs) allow cancer cells to adapt to microenvironmental 
tissue hypoxia, affecting all aspects of tumor progression, including metabolism, 
proliferation, inflammation, angiogenesis, and metastasis.2–5 Importantly, HIFs are 
also involved in resistance to cancer therapy, and overall survival correlates with 
HIFα levels in a cancer type-specific manner.6–8 Transcriptionally active HIFs are 
heterodimers usually composed of a constitutively expressed β subunit and either 
a HIF-1α or a HIF-2α subunit, the stability and activity of which is regulated by 
oxygen-dependent protein hydroxylation.9,10 Despite their high structural similarity 
and identical DNA sequence recognition, several studies have identified specific 
roles for HIF-1 and HIF-2 in tumorigenesis.11–13 We and others previously showed 
in a variety of cancer cell lines that HIF-1α protein levels decreased under pro-
longed hypoxia while HIF-2α levels increased, suggesting HIFα isoform-specific 
kinetics of target gene expression.8,14,15 In contrast with the many known HIF-1 and 
HIF-1/HIF-2 target genes,8,14,16 only a few genes have been reported to be regulated 
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exclusively by HIF-2, including  erythropoietin, ephrin A1, 
VE-cadherin, protein tyrosine phosphatase receptor-type Z 
polypeptide 1, amphiregulin, and Wnt-1 induced signaling 
protein 2 (WISP-2).8,14,17–21
WISP-2 is a secreted protein member of the connective 
tissue growth factor/cysteine-rich 61/nephroblastoma over-
expressed (CCN) family, and is also known as CCN5.22,23 
WISP-2 has been detected in adult skeletal muscle, colon, and 
ovary, and in the fetal lung, as well as in the stroma of breast 
tumors derived from Wnt-1 transgenic animals.24 WISP-2 
expression has been shown, in most studies, to correlate 
inversely with the aggressiveness of breast, pancreatic, and 
colon cancer, suggesting tumor suppressor-like activity.25,26 
WISP-2 shows transiently elevated levels during progression 
of breast cancer; while it is almost undetectable in normal 
human mammary epithelial cells, it is highly expressed in 
estrogen receptor-positive noninvasive breast cancer cell 
lines (including MCF-7, BT-474, ZR-75-1, and T-47D), and 
is again undetectable in highly invasive estrogen receptor-
negative cells (including MDA-MB-231, MDA-MB-468, 
BT-20, and DU-4475).27–30 Loss of WISP-2 in MCF-7 
cells induced estrogen-independent growth and promoted 
epithelial-to-mesenchymal transition, consistent with a more 
invasive phenotype, whereas forced WISP-2 expression in 
MDA-MB-231 cells reduced proliferation and invasiveness.30 
WISP-2 expression is induced by estrogens as well as by 
epidermal growth factor and insulin-like growth factor in 
estrogen receptor-positive cells, and WISP-2 is necessary 
for estrogen-induced and insulin-like growth factor-induced 
proliferation.31–35
A functional estrogen response element has been iden-
tified in the WISP2 promoter which is required for induc-
ibility of the WISP2 gene by estrogen.29 Estrogen receptor-α 
recruits the histone acetyl transferase cAMP response 
element (CRE) binding (CREB) protein as well as the 
cyclin-dependent kinase inhibitor p21WAF1/CIP1 to the WISP2 
promoter, suggesting cooperative control of WISP2 gene 
expression.29,36 Hypoxia has been identified as another stimu-
lus of WISP2 gene expression, and is mediated specifically 
by HIF-2α in cooperation with the ETS oncogene family 
member  ETS-like gene 1 (ELK-1) in MCF-7 cells.14,37 We 
previously demonstrated that the WISP2 promoter is induced 
specifically by HIF-2α in MCF-7 cells.8 Here, we identified 
the hypoxia response elements (HREs) and characterized a 
microsatellite region responsible for HIF-2α-specific induc-
tion of the WISP2 promoter.  Furthermore, we assessed the 
impact of hypoxia and HIF-2α on WISP-2-mediated cell 
proliferation, clonogenic growth, and motility.
Materials and methods
cell culture and transfection
Human breast cancer cell lines (MCF-7, T-47D, ZR-75-1, 
BT-474, MDA-MB-468, and MDA-MB-231) were cultured in 
high-glucose Dulbecco’s Modified Eagle’s Medium (Sigma-
Aldrich, St Louis, MO, USA). Hypoxic experiments were 
performed at 1% oxygen and 5% CO
2
 in a gas-controlled 
glove box (Invivo2 400, Ruskinn Technology Limited, 
 Bridgend, UK) as described previously.38 Viral particles were 
generated in HEK293T cells following cotransfection of 
the transfer vector (3 µg) together with the packaging plas-
mids, ie, pLP1 (4.2 µg), pLP2 (2 µg), and pVSV-G (2.8 µg) 
(Invitrogen, Carlsbad, CA, USA) using polyethylenimine 
(Polysciences, Warrington, PA, USA). MCF-7 cells were 
infected with viral particles and cell pools were selected with 
puromycin as described before.38 Two independent WISP-2 
short hairpin RNA (shRNA) vectors (TRCN0000033355 
and TRCN0000033357) were obtained from Sigma-Aldrich. 
shRNA-resistant HIF-2α was used to rescue MCF-7 cells 
with stable HIF-2α knockdown, as described before.8
Messenger rna (mrna) and protein 
detection
Total cellular RNA was extracted as previously described.39 
Total RNA (2 µg) was reverse transcribed using Affinity-
Script reverse transcriptase (Agilent, Santa Clara, CA, USA) 
and complementary DNA (cDNA) levels were estimated 
by quantitative polymerase chain reaction (PCR) using a 
SYBR® Green quantitative PCR reagent kit (Sigma-Aldrich) 
in a MX3000P light cycler (Agilent). Transcript levels 
were calculated by comparison with a calibrated standard 
and expressed as ratios relative to ribosomal protein L28 
mRNA levels. Immunoblots were performed as previously 
described.40 Antibodies against the following proteins were 
used: WISP-2 (Abcam, Cambridge, UK), HIF-1α (BD 
Transduction Laboratories, Allschwil, Switzerland), HIF-2α 
(Novus Biologicals, Littleton, CO, USA), Sp1 (Santa Cruz 
Biotechnology, Dallas, TX, USA), and β-actin (Sigma-
Aldrich). Breast cancer tissue microarray analysis has been 
described previously.8
Plasmid construction and reporter  
gene assays
The promoter truncations −1919/+16, −808/+16, −520/+16, 
and −422/+16 have been reported elsewhere29 and were kindly 
provided by M Sabbah (Paris, France); −422/−75, −83/+16, 
and MS deletions were generated by standard  cloning tech-
niques. The WRE1, CRE, ELK-1, and WRE2 sites in the 
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−422/+16 construct were mutated by site-directed muta-
genesis. The −252/+16  truncation was generated by PCR 
cloning. The −422 (CA)
n
 promoter region was amplified from 
T-47D genomic DNA, transformed into bacteria, and iso-
lated for sequencing to determine the CA repeat length. The 
−112/+16 and −112/+16 HRE2/3 double-mutant constructs 
were generated by elongation of an internal MluI site using 
double-stranded oligonucleotides. HRE2 and HRE3 in the 
−422/+16 construct were mutated by site-directed mutagen-
esis (5′-CGTG-3′ to 5′-CAAA-3′). Dual luciferase reporter 
gene assays were performed as described previously.41 The 
promoterless luciferase vector pGL3basic was included as 
negative control in all experiments.
genomic Dna extraction  
and sequencing
Cells were washed with phosphate-buffered saline, resus-
pended in high salt lysis buffer (200 mM NaCl, 50 mM 
Tris/HCl pH 8.0, 50 mM ethylenediaminetetraacetic 
acid [EDTA] pH 8.0, 1% sodium dodecyl sulfate) and 
treated overnight with proteinase K (0.5 mg/mL). After 
addition of saturated NaCl, DNA was precipitated with 
 isopropanol, washed with 70% ethanol, and resuspended 
in Tris/EDTA buffer. WISP-2 genomic DNA was ampli-
fied by PCR using forward primer 5′-TACGGGTACCAC
GGACAGGCACCCCCTTGGTGG-3′ and reverse primer 
5′-CAGATGTGCAGAGCCAGCAGCTT-3′. PCR products 
were gel-purified and sequenced (Microsynth AG, Balgach, 
Switzerland).
cellular proliferation, colony  
formation and motility assays
To determine cell proliferation and viability, 105 cells per 
well were seeded into six-well plates, allowed to adhere 
overnight, exposed to normoxia or hypoxia for 0 to 72 hours, 
detached by trypsin/EDTA, and counted using a Vi-cell™ 
XR cell viability analyzer (Beckman-Coulter, Brea, CA, 
USA). For low cell density colony-forming assays, 2 × 103 
cells per well were plated into six-well plates, allowed to 
adhere overnight, and exposed to normoxia or hypoxia for 
10 days, with the medium replaced every 3 days. The colonies 
were fixed with methanol, stained with 0.5% crystal violet, 
and counted. For anchorage-independent colony formation 
assays, 104 cells were resuspended in 2 mL of 0.4% low melt-
ing agarose (Sigma-Aldrich) in Dulbecco’s Modified Eagle’s 
Medium, poured on top of a 2% low melting agarose layer 
in six-well plates, and allowed to settle overnight. Following 
exposure to normoxia or hypoxia for 14 days, the soft agar 
was washed with phosphate-buffered saline, the colonies 
were stained with 0.005% crystal violet in methanol for one 
hour at room temperature, and counted. For the scratch assay, 
cells were allowed to grow to 100% confluency in 12-well 
plates. Following crosswise scratching with a 200 µL pipette 
tip, the cells were exposed to normoxia or hypoxia in fetal 
calf serum-free Dulbecco’s Modified Eagle’s Medium for 
24 hours. The cell-free area was measured and converted to 
percent recovery.
statistical analysis
If not indicated otherwise, unpaired Student’s t-tests were 
applied. Differences between two values at the P,0.05 level 
were considered to be statistically significant.
Results
HiFα isoform responsible for hypoxic  
WISP-2 induction is specific for distinct  
breast cancer cell lines
To determine the HIFα isoform directing WISP-2  expression 
in breast cancer, four luminal-like (MCF-7, BT-474, T-47D, 
and ZR-75-1), one basal A-like (MDA-MB-468), and one 
basal B-like (MDA-MB-231) human breast cancer cell 
line were analyzed. Similar to data published elsewhere,8,30 
 constitutive WISP-2 mRNA levels were high in MCF-7 
cells, moderate in T-47D and BT-474 cells, low in ZR-75-1 
cells, and almost undetectable in MDA-MB-231 and MDA-
MB-468 cells (Figure 1A). Although WISP-2 immunoblot-
ting is notoriously difficult,42 probably because the WISP-2 
protein is partially secreted we managed to detect WISP-2 
protein in MCF-7 cells where it was found to be upregulated 
following hypoxic stimulation (Figure 1B), as previously 
published for the WISP-2 mRNA levels.8
Immunoblot analyses revealed that all six cell lines 
expressed both HIF-1α and HIF-2α in a hypoxia-inducible 
manner (Figure 1C). The variable relative molecular weight 
of HIF-1α between approximately 98 kDa and 120 kDa, 
as observed in the different cell lines, is due to varying 
degrees of phosphorylation as reported previously.43 
HIF-1α and HIF-2α were stably knocked down by viral 
transduction of shRNA constructs. Exogenous shRNA 
expression efficiently reduced HIFα levels (Figure 1C). 
In the absence of HIF-1α, increased HIF-2α protein levels 
could be observed in most cell lines, a currently unex-
plained phenomenon that we and others have described 
previously.8,44
As in MCF-7 cells,8 robust hypoxic WISP-2 mRNA 
induction was also found in T-47D, BT-474, and ZR-75-1 
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cells (Figure 1D). No hypoxic WISP-2 induction could be 
detected in MDA-MB-231 and MDA-MB-468 cells (data 
not shown). Knockdown of the HIFα isoforms demon-
strated that WISP-2 mRNA is predominantly regulated 
by HIF-2α in MCF-7 and T-47D cells (Figure 1D). In 
MCF-7 cells, HIF-2α shRNA also prevented the hypoxic 
induction of WISP-2 but not of prolyl-4-hydroxylase 
domain 2  protein levels, the latter being an HIF-1α target 
(Figure 1B).  However, in BT-474 cells, hypoxic WISP-2 
mRNA induction was HIF-1α-dependent but not HIF-2α-
dependent, and in ZR-75-1 cells hypoxic WISP-2 mRNA 
induction was attenuated in the absence of both HIF-1α and 
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Figure 1 HiFα isoform-specific regulation of WISP-2 transcription. (A) Basal WisP-2 mrna levels were determined by reverse transcription quantitative polymerase chain 
reaction in the six breast cancer cell lines indicated using a calibrated internal standard. shown are mean values ± the standard error of the mean of three independent 
experiments. (B) McF-7 cells were cultured in normoxic conditions or exposed to hypoxia for 24 hours, and analyzed by immunoblotting using antibodies derived against 
WisP-2, the HiF target prolyl-4-hydroxylase domain 2 (PHD2), HiF-2α, or the constitutively expressed control protein, β-actin. (C) cells were stably transfected with 
either control shrna or shrnas targeting HiF-1α (shH1a) or HiF-2α (shH2a) and analyzed by immunoblotting of nuclear extracts using antibodies derived against HiF-
1α, HiF-2α, or the constitutively expressed control transcription factor, sp1. (D) Hypoxic WisP-2 mrna induction was determined in the indicated cell lines which were 
stably transfected with either control or shrna constructs as in (C). WISP-2 mRNA levels were quantified by reverse transcription quantitative polymerase chain reaction 
and normalized to the mrna levels of the ribosomal protein, l28. shown are mean values ± the standard errors of the mean of three independent experiments. (D) For 
statistical evaluation of the hypoxically exposed cells, the effects of HiF-1α or HiF-2α silencing were compared with the control shrna transfected cells. *P,0.05; **P,0.01; 
***P,0.001.
Abbreviations: ctrl, control; HiF, hypoxia-inducible factor; WisP-2, Wnt-1 induced signaling protein 2; mrna, messenger rna.
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HIF-2α  (Figure 1D). These data demonstrate that WISP-2 
is regulated by hypoxia in low-invasive luminal-like breast 
cancer cell lines and that cancer-specific HIFα isoforms 
confer hypoxic WISP-2 induction.
Potential enhancer elements involved in 
HiF-inducible WISP2 promoter activity
To further investigate the HIFα isoform-specific effect on 
WISP-2 transcription, we tested various WISP2 promoter 
truncations driving firefly luciferase reporter gene  expression 
in MCF-7 cells. All constructs ranging from −1929/+16 
to −422/+16 relative to the transcriptional start site of the 
human WISP2 gene displayed similar promoter activities. 
In contrast with the robust hypoxic WISP-2 mRNA induc-
tion (Figure 1C), only weak responses to hypoxia could be 
observed with these reporter gene constructs (Figure 2A). 
Whereas moderate increases in promoter activity, mainly 
under hypoxic conditions, were observed after HIF-1α 
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(A) Promoter truncations from positions −1919 to −422 upstream of the transcriptional start site. (B) Potential hypoxia response elements are depicted by black marks 
(upper panel). HiF responsiveness was lost in the minimal promoter (lower panel). (C) Four potential hypoxia response elements in the WISP2 5′ flanking region are indicated 
in red. (D) McF-7 shH2a cells were cotransfected with either the wild-type (−422) promoter construct or constructs bearing the indicated mutations, together with either 
an empty (e) vector, or a HiF-1α (H1) or HiF-2α (H2) overexpression vector. shown are mean values ± the standard errors of the mean of three (four for D) independent 
experiments performed in triplicate. For statistical evaluation, the effects of HiF-1α and HiF-2α overexpression were compared with the respective empty vector controls 
(A and B), or were first normalized to the empty vector control values and then compared with the respective normalized values of the wild-type −422/+16 promoter 
construct (D). *P,0.05; **P,0.01; ***P,0.001.
Abbreviations: HiF, hypoxia-inducible factor; WisP-2, Wnt-1 induced signaling protein 2; rlU, relative light units; Hre, hypoxia response element; Ms, microsatellite 
repeat; gB, gene Bank; Wre, WnT response elements; cre, caMP response element; elK-1, eTs-like gene 1; pgl3basic, promotorless basic luciferase vector.
Hypoxia 2014:2submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
28
Fuady et al
 overexpression, strong increases in normoxic as well as 
hypoxic promoter activities followed HIF-2α overexpression, 
suggesting that HREs likely are present on these constructs 
but are not sufficient to confer full hypoxic inducibility. 
Additional truncations of the −422/+16 construct resulted 
in complete loss of promoter activity in the absence of the 
region close to the TATA-like box (construct −422/−75), dem-
onstrating that the first 75 base pairs are essential for basal 
promoter activity. Normal basal activity but unresponsiveness 
to HIFα overexpression was observed for construct −83/+16 
(Figure 2B).
Three single putative HREs (HRE1, HRE2, and HRE3) 
and a double HRE (HRE4) were identified in the WISP2 
promoter region (Figure 2C). Of note, the three single HREs 
were all located within microsatellite (MS) regions. HRE1 
was found in a CA repeat region denominated MS I, HRE2 
was located at the transition between a GT and a GC repeat, 
collectively named MS II, and HRE3 was identified within 
the GC repeat of MS II (Figure 2C). Furthermore, a phylo-
genetic footprint analysis of the promoter region revealed 
a strong sequence conservation around the TATA-like box, 
comprising a potential CRE, a binding site for ELK-1, and 
two WNT response elements (WREs, Figure 2C). However, 
when tested in MCF-7 shH2a cells with suppressed endog-
enous HIF-2α levels, WRE1 mutation neither affected basal 
promoter activity nor HIFα responsiveness. Mutation of the 
CRE site strongly decreased promoter activity but partially 
retained HIF-2α-mediated induction. Similarly, the ELK 
and WRE2 mutations reduced overall promoter activity and 
slightly affected HIF-2α responsiveness (Figure 2D). In 
conclusion, these conserved elements are mainly required 
for basal promoter activity but do not seem to confer HIF-
2α-dependent induction of the WISP2 promoter, although we 
cannot exclude a partial cooperation between these cis-acting 
elements and the HREs.
Two Hres within an Ms repeat regulate  
HiF-dependent WisP-2 transcription
To identify the HRE(s) responsible for HIF-mediated 
WISP-2 regulation, MS I (containing HRE1) was removed by 
a −252/+16 promoter truncation (∆MS I), and MS II (contain-
ing HRE2 and HRE3) was removed by a promoter deletion 
(∆MS II) as indicated in Figure 2C.  Overexpression of both 
HIFα isoforms in stable HIF-2α knockdown MCF-7 cells 
was used to drive reporter gene expression. HIFα-dependent 
induction of the ∆MS I construct in stable HIF-2α knock-
down MCF-7 cells was indistinguishable from the −411/+16 
construct, indicating that MS I does not contain a functional 
HRE. In contrast, HIFα-dependent induction of reporter 
gene activity was strongly reduced when MS II was deleted 
(Figure 3A).
Deletion of the MS II resulted in basal reporter gene 
expression comparable with minimal WISP2 promoter 
(−83/+16) activity (Figure 3B). These experiments were 
repeated in wild-type MCF-7 cells with a similar outcome 
(data not shown). Furthermore, the −83/+16 minimal 
 promoter construct was extended with oligonucleotides 
containing either wild-type (−112/+16) or mutated 
(−112/+16mut) HRE2 and HRE3, as indicated in Figure 2C. 
While no differences in activity were observed between 
the −112/+16mut and the −83/+16 constructs, a partial but 
significant reconstitution of HIF-2α-mediated WISP2 pro-
moter induction was observed with the −112/+16 construct 
under hypoxic  conditions ( Figure 3B). In conclusion, these 
results demonstrate that HRE2 and/or HRE3 within MS II 
mainly confer HIF responsiveness to the WISP2 promoter.
Because MS instability is a hallmark of cancer,45 we tested 
whether differences in the length of the CA repeats in MS II 
might influence HIFα-inducible promoter activity. Therefore, 
genomic DNA from T-47D cells was amplified and cloned. 
CA repeat length variants, CA
12
, CA
13
, CA
17
, and CA
18
, were 
obtained and compared with the parental −422/+16 construct 
derived from MCF-7 cells (Figure 3C). However, no change 
in reporter gene activity could be observed, suggesting 
that MS instability does not affect HIFα-mediated WISP2 
 promoter activity.
Unexpectedly, sequencing of the WISP2 upstream 
regulatory region revealed the presence of HRE2 in all 
breast cancer cell lines analyzed (Figure 1), as well as in 
Hep3B and HepG2 hepatoma, SK-N-MC neuroepithelioma, 
and HeLa cervical carcinoma, but not in three published 
sequences (GRCh37.p2, HuRef, and Hs_Celera). Only 
UT-7 megakaryoblastic leukemia cells lacked HRE2 and 
showed the same sequence as the database entries (data 
not shown). Therefore, the −252/+16 region was amplified 
from UT-7 cells (−252/+16_UT7) and compared with the 
promoter constructs derived from MCF-7 cells. Only a small 
reduction in response to HIFα overexpression was observed 
with the −252/+16_UT7 construct (Figure 3D). Also, muta-
tion of HRE3 (∆HRE3) resulted in a modest reduction in 
reporter gene activity, and a double mutation of HRE2 and 
HRE3 (∆HRE2/∆HRE3) further abrogated reporter gene 
activity comparable with that observed after deletion of 
MS II  (Figure 3E). Taken together, these results indicate 
that the two HREs within MS II mediate at least partially 
HIFα-dependent induction of the WISP2 promoter.
Hypoxia 2014:2 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
29
HiF-mediated induction of WisP-2 in breast cancer
Figure 3 Identification of the hypoxia response elements responsible for HIF-mediated induction of WISP-2 transcription. Dual luciferase reporter gene experiments 
in McF-7 shH2a cells transfected with either an empty vector (e), or a HiF-1α (H1) or HiF-2α (H2) overexpression vector together with the indicated firefly luciferase 
constructs and a renilla luciferase control vector, after 24 hours under normoxic or hypoxic (1% O2) conditions. (A) WISP2 promoter constructs lacking either Ms i (∆Msi) 
or Ms ii (∆Msii) were compared with the −422/+16 construct. (B) WISP2 promoter constructs containing wild-type (−112/+16) or mutant Hre2 and Hre3 (−112/+16mut) 
were compared with the ∆Msi, ∆Msii or minimal promoter (−83/+16) constructs. (C) WISP2 promoter constructs containing the indicated Ms repeat length polymorphisms 
identified in T-47D cells were compared with the −422/+16 fragment derived from McF-7 cells. (D) WISP2 promoter constructs containing the HRE2-deficient sequence 
identified in UT-7 cells (−252/+16_UT7) were compared with the corresponding fragment (−252/+16) and the minimal promoter (−83/+16) derived from McF-7 cells. shown 
are the mean values ± standard deviations of representative experiments performed in quadruplicate. (E) WISP2 promoter constructs containing the −252/+16 fragment, 
either wild-type (−252/+16), Hre2 mutant (∆Hre2) or Hre2 and Hre3 double mutant (∆Hre2/∆Hre3), were compared with the ∆Msii construct. shown are the mean 
values ± standard deviations of three independent experiments performed in quadruplicate. For statistical evaluation, the effects of HiF-1α and HiF-2α overexpression were 
first normalized to the empty vector control values and then compared with the respective normalized values of the wild-type −422/+16 (A and C) or −252/+16 (D and E) 
promoter constructs. (B) similarly, the activities of −112/+16 and −112/+16mut were compared with the −83/+16 minimal promoter. *P,0.05; **P,0.01; ***P,0.001.
Abbreviations: HiF, hypoxia-inducible factor; WisP-2, Wnt-1 induced signaling protein 2; rlU, relative light units; Hre, hypoxia response element; Ms, microsatellite 
repeat; pgl3basic, promotorless basic luciferase vector.
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WisP-2 negatively correlates with tumor 
infiltration by macrophages
We previously reported that high WISP-2 levels correlate posi-
tively with high HIF-2α levels and prolonged overall survival 
in patients with breast cancer.8 Because tumor macrophage 
infiltration, associated with the hypoxic tumor microenviron-
ment and high HIFα levels, not only represents an important 
step during progression of breast cancer but also an important 
prognostic marker,46,47 we analyzed whether WISP-2 expres-
sion levels are related to tumor-associated macrophage counts. 
Therefore, over 300 breast cancer samples were immuno-
stained and scored for the macrophage markers CD68 and 
CD163 and the pan-leukocyte marker CD45 (Figure 4A). 
Interestingly, a negative correlation between WISP-2 and 
tumor-associated macrophage counts was found (Figure 4B). 
As expected, overall survival of these patients was negatively 
associated with macrophage infiltration (Figure 4C). These 
results suggest that HIF-2α-mediated WISP-2 expression is 
a marker for (and maybe is even causally involved in) breast 
cancer progression stage, with low cancer cell proliferation/
invasiveness as well as low macrophage infiltration, and both 
contributing to an improved prognosis.
HiF modulates the WisP-2 suppressed  
motility of McF-7 cells
Silencing of WISP-2 in noninvasive MCF-7 cells has been 
reported to enhance motility and modulate the  expression 
of genes involved in cancer invasiveness.30,48,49 To inves-
tigate the functional consequences of HIF-mediated 
WISP-2 regulation, we stably transfected MCF-7 cells 
with WISP-2 shRNA, resulting in a robust knockdown of 
WISP-2 mRNA using two independent shRNA  constructs 
(shW#1 and shW#2) under normoxic as well as hypoxic 
conditions (Figure 5A). Proliferation of both WISP-2 
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knockdown cells, but not of previously established 
HIF-2α knockdown cells,8 was significantly impaired under 
both normoxic and hypoxic conditions (Figure 5B). As 
determined by automated trypan blue exclusion and video 
microscopy analysis, no difference in gross cell morphol-
ogy or viability could be observed (data not shown). Low 
cell density colony formation was somewhat attenuated 
by knockdown of both HIF-2α and WISP-2 (Figure 5C). 
In contrast, anchorage-independent colony formation 
was increased, especially in normoxic cells (Figure 5D). 
 Similarly, recovery from scratches in confluent cell layers 
was significantly increased by knockdown of both HIF-2α 
and WISP-2 (Figure 5E). Probably owing to remaining weak 
WISP-2 induction (see Figure 5A), under hypoxic conditions 
a slightly impaired anchorage-independent colony formation 
(Figure 5D) as well as scratch recovery of MCF-7 cells was 
observed (Figure 5E), although the values were still higher 
than in the hypoxic control cells. In summary, these results 
are consistent with a role of HIF-2 in WISP-2-mediated sup-
pression of MCF-7 anchorage-independent growth and cell 
motility, which are two hallmarks of cancer progression.
Discussion
In this study, we could corroborate the previously reported 
hypoxic induction of WISP-28 which was HIF-2-dependent 
in most but not all low-invasive breast cancer cell lines tested, 
suggesting that currently unknown cell type-specific cofac-
tors determine the HIFα isoform responsible for hypoxic 
WISP-2 induction, rather than intrinsic gene selectivity 
of the HIFα isoforms themselves. Previous studies have 
suggested a cooperation of HIF-2α, but not HIF-1α, with 
ETS factors resulting in target selectivity,14,50 but whether a 
different composition of ETS factors explains the HIF-1α-
specific WISP-2 expression in BT-474 cells remains to be 
explored. Although we observed lower basal levels of WISP2 
promoter activity following mutation of the conserved CRE, 
ELK-1, and WRE sites, HIF-2α-mediated WISP-2 regula-
tion remained unaffected, suggesting that none of these 
factors confers HIFα isoform selectivity.
Two functional HREs were identified which are essential 
for HIF-2α-specific induction of WISP2 promoter activity in 
MCF-7 cells, but even promoter constructs up to 1,919 base 
pairs upstream of the transcriptional start site did not fully 
recapitulate the hypoxic induction factors determined at the 
mRNA level. Of note, in a genome-wide chromatin immu-
noprecipitation study, both HIFα isoforms were reported 
to bind to a region within the first intron of WISP-2,51 sug-
gesting that these elements might contribute to endogenous 
regulation of WISP-2. However, at least in MCF-7 cells, we 
could not detect any further increase in hypoxic WISP-2 
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transcription by this region in combination with the upstream 
regulatory elements (data not shown). The two functional 
HREs are located within the highly polymorphic MS II 
region of the WISP2 promoter. Such unstable polymorphic 
dinucleotide repeats are known to play an important role in 
tumor progression. MS instability seems to be mostly due 
to the loss of a functional mismatch repair machinery, and 
is implicated in prognosis and therapy response because it 
alters the expression levels of the affected genes.45,52 How-
ever, we could not find any role for MS II length in regulating 
reporter constructs driven by the WISP2 promoter.
By immunohistochemical analysis of breast cancer 
samples, we recently demonstrated that HIF-2α and WISP-2 
levels correlate with a more differentiated tumor cell type 
and consistently with a better prognosis.8 These results 
are in line with the findings presented herein showing that 
WISP-2 negatively correlates with tumor macrophage inva-
sion, which provides an additional marker for a  better tumor 
prognosis. Silencing of WISP-2 elevated two parameters 
of cancer cell aggressiveness, ie, anchorage-independent 
colony formation and recovery from scratches in confluent 
cell layers. These effects could not simply be explained by 
changes in proliferation rates and anchorage-dependent 
colony formation, which were actually slightly decreased 
rather than increased. Interestingly, increased anchorage-
independent colony formation and scratch recovery follow-
ing WISP-2 knockdown could be phenocopied by HIF-2α 
silencing. While we cannot exclude that additional signaling 
pathways are recruited by the hypoxic tumor microenvi-
ronment, our data strongly suggest that HIF-2-mediated 
WISP-2 induction contributes to a less aggressive tumor 
type.
Conclusion
Taken together, our data suggest that the previously reported 
association between high HIF-2α levels and an increased 
overall survival rate in patients with breast cancer could be 
explained at least partially by HIF-2α-mediated direct induc-
tion of WISP-2, maintaining a less aggressive breast cancer 
phenotype.
Figure 5 role of HiF-2α and WisP-2 in McF-7 proliferation and motility. (A) McF-7 cells were stably transfected by lentiviral infection with control or two independent 
WISP-2 shRNA constructs (shW#1 and shW#2). Following normoxic or hypoxic (24 hours, 0.2% O2) exposure, WisP-2 mrna (messenger rna) levels were determined 
by reverse transcription quantitative polymerase chain reaction and normalized to the mrna levels of the ribosomal protein l28. shown are the mean values ± standard 
deviations of five independent experiments. (B) Proliferation of McF-7 cells kept under normoxic or hypoxic conditions for up to 3 days was determined by cell counting, 
and cell numbers were normalized to the number of cells initially seeded. shown are the mean values ± standard deviations of three independent experiments performed 
in triplicate. Differences after 3 days relative to the nontransfected controls were analyzed by student’s t-test. (C) low-density colony formation of McF-7 cells cultured 
under normoxic or hypoxic conditions for 10 days. shown are the colony numbers of three measurements in triplicate and the corresponding mean values. (D) anchorage-
independent colony formation of McF-7 cells cultured in soft agar under normoxic or hypoxic conditions for 14 days. shown are the colony numbers of 4–5 triplicate 
measurements and the corresponding mean values. (E) Recovery of scratched confluent MCF-7 cell layers after 24 hours of normoxic or hypoxic (0.2% O2) exposure. 
shown are the results of 4–5 independent experiments. For statistical evaluation, all values were compared with the respective control shrna transfected cells. *P,0.05; 
**P,0.01; ***P,0.001.
Abbreviations: HiF, hypoxia-inducible factor; WisP-2, Wnt-1 induced signaling protein 2; norm, normoxia; Hyp, hypoxia; ctrl, control.
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